Japan Auto-injectors Market Size & Outlook, 2026-2033
Related Markets
Japan auto-injectors market highlights
- The Japan auto-injectors market generated a revenue of USD 552.7 million in 2025 and is expected to reach USD 1,604.7 million by 2033.
- The Japan market is expected to grow at a CAGR of 14.4% from 2026 to 2033.
- In terms of segment, rheumatoid arthritis was the largest revenue generating disease indication in 2025.
- Diabetes is the most lucrative disease indication segment registering the fastest growth during the forecast period.
Auto-injectors market data book summary
| Market revenue in 2025 | USD 552.7 million |
| Market revenue in 2033 | USD 1,604.7 million |
| Growth rate | 14.4% (CAGR from 2026 to 2033) |
| Largest segment | Rheumatoid arthritis |
| Fastest growing segment | Diabetes |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anaphylaxis, Diabetes, Rheumatoid Arthritis, Other Therapies, Multiple Sclerosis |
| Key market players worldwide | Eli Lilly and Co, SHL Medical, AbbVie Inc, Amgen Inc, Owen Mumford, Ypsomed Holding AG, Teva Pharmaceutical Industries Ltd, Biogen Inc, Mylan, Pfizer Inc, Sanofi SA, Gerresheimer AG ADR |
Other key industry trends
- In terms of revenue, Japan accounted for 5.4% of the global auto-injectors market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan auto-injectors market is projected to lead the regional market in terms of revenue in 2033.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 423.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Auto-Injectors Market Scope
Auto-Injectors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mylan | View profile | 10001+ | https://www.mylan.in/ | |
| SHL Medical | View profile | 1001-5000 | Zug, Zug, Switzerland, Europe | https://www.shl-medical.com/ |
| Owen Mumford | View profile | 501-1000 | Oxford, Oxfordshire, United Kingdom, Europe | http://www.owenmumford.com/en/ |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Gerresheimer AG ADR | View profile | 11660 | Klaus-Bungert-Strasse 4, Duesseldorf, NW, Germany, 40468 | https://www.gerresheimer.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Japan auto-injectors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to auto-injectors market will help companies and investors design strategic landscapes.
Rheumatoid arthritis was the largest segment with a revenue share of 33.24% in 2025. Horizon Databook has segmented the Japan auto-injectors market based on anaphylaxis, diabetes, rheumatoid arthritis, other therapies, multiple sclerosis covering the revenue growth of each sub-segment from 2021 to 2033.
The auto-injectors market in Japan is poised for rapid growth, driven by innovations in autoinjectors. such as battery-free, high-tech patches for monitoring lifestyle-related diseases such as heart disorders, stress indicators, and sleep apnea.
These advancements offer continuous health monitoring with minimal discomfort, appealing to Japan's aging population and their increasing focus on health management.
Reasons to subscribe to Japan auto-injectors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan auto-injectors market databook
-
Our clientele includes a mix of auto-injectors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan auto-injectors market, including forecasts for subscribers. This country databook contains high-level insights into Japan auto-injectors market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Japan auto-injectors market size, by disease indication, 2021-2033 (US$M)
Japan Auto-Injectors Market Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
